WASHINGTON, Jan. 2, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024 at 2:15 p.m. ET. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading… Continue reading Danaher to Present at J.P. Morgan Healthcare Conference
Tag: Morgan
Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 2, 2024 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.… Continue reading Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 2, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 42nd Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Tuesday January 9, 2024 in San Francisco. Kevin Gorman, Chief Executive Officer, will present at the conference. The live presentation will be webcast and may be accessed… Continue reading Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 2, 2024 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8 at approximately 3:45 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the… Continue reading Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Jan. 2, 2024 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Oguzhan Atay, PhD, CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 10, 2024. Presentation details… Continue reading BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 2, 2024 /PRNewswire/ — Totus Medicines, a company revolutionizing small molecule drug discovery and development through the use of covalent libraries and AI tools, announced today today announced that Totus President and CEO, Nassim Usman, Ph.D., will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San… Continue reading Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill., Jan. 2, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar,… Continue reading AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NEW HAVEN, Conn., Jan. 2, 2024 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California, on Monday, January 8, 2024 at 8:15 am (PT). A slide deck of the presentation will be available on… Continue reading Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase
SHANGHAI, Jan. 2, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, R&D VP of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase in San Francisco, United States. Dr. Hai Wu will introduce Mabwell’s global collaboration strategy, innovative pipeline covering therapeutic… Continue reading Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase
Systems Spray-Cooled erhält Auftrag von Hybar
NASHVILLE, Tennessee, 2. Januar 2024 /PRNewswire/ — Hybar, LLC hat Systems Spray-Cooled für die Lieferung von Spray-Cooled™ EAF-Anlagen für das neue Betonstahlwerk von Hybar in Osceola, Arkansas, ausgewählt. Das neue Werk wird auf der grünen Wiese auf einer Fläche von 1.300 Acres im Nordosten von Arkansas errichtet. Continue Reading Representative Spray-Cooled™ Electric Arc Furnace Die… Continue reading Systems Spray-Cooled erhält Auftrag von Hybar